STEXNasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
Streamex Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.37−0.00 (-0.80%)
Close on Oct 19, 2026
- Market cap
- $67.53M
- P/E (TTM)
- –
- Dividend yield
- –
Streamex Corp. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Corporate Segment [Member] | -$146.00K | – | – | – | – | – | $13.00K | $0 | $13.00K | $14.00K | $12.00K | $1.00K | -100.0% | – |
| ViralClear Pharmaceuticals, Inc. [Member] | – | – | – | – | – | – | – | – | $13.00K | $14.00K | – | – | – | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Corporate Segment [Member] | – | – | – | – | – | – | – | -$2.95M | -$5.29M | -$3.39M | -$5.74M | -$5.53M | – |
| BioSig AI Sciences, Inc. [Member] | – | – | – | – | – | – | – | $0 | $0 | -$3.00K | -$338.00K | -$389.00K | – |
| ViralClear Pharmaceuticals, Inc. [Member] | – | – | – | – | – | – | – | $0 | -$4.00K | -$41.00K | -$85.00K | $1.86M | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Streamex's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.